US Patent Issued to VERRA THERAPEUTICS on March 11 for "Methods and compositions for inhibiting ADAM 9 biological activities" (North Carolina, New York Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,232, issued on March 11, was assigned to VERRA THERAPEUTICS INC. (Lansing, N.Y.).

"Methods and compositions for inhibiting ADAM 9 biological activities" was invented by Marcia L. Moss (Apex, N.C.), Robert Rasmussen (Lansing, N.Y.) and Chris Prince (Ithaca, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are ADAM9 modulating peptides and methods for using the same to modulate ADAM9 biological activities in vitro and/or in vivo, to inhibit ADAM9 biological activities associated with diseases or disorders in subjects, to decrease inflammation, and to inhibit undesirable cellular proliferation, fibrosis, and angiogenesis. In some embodimen...